Governance Classic Home
Neuland Laboratories LtdPharmaceuticalsINE794A01010Consolidated₹22875.70+219.50 (+0.97%)Jun-26
Valuation
Market Cap₹29.30K Cr
TTM PE58.87x
Forward PE54.82x
PEG1.60
Book Value₹1461.02
P/B15.63x
TTM EPS₹387.97
Fwd EPS₹416.64
TTM Revenue₹2.37K Cr
TTM PAT₹497.76 Cr
TTM EBITDA₹762.90 Cr
TTM EBIT₹664.79 Cr
Last Qtr PAT₹147.67 Cr
Last Qtr EBITDA₹222.89 Cr
Last Qtr EBIT₹196.33 Cr
Profitability
ROE26.55%
ROCE33.34%
TTM NPM20.99%
TTM EBITDA %32.17%
Curr OPM22.72%
Last OPM26.96%
Curr NPM—
Last NPM—
Curr EPS₹115.10
Last EPS₹165.76
Balance sheet
Equity₹12.90 Cr
Reserve₹1.86K Cr
Total Debt₹211.62 Cr
D/E0.11x
Interest %4.72%
Curr Interest₹6.97 Cr
Price / range
Close₹22840.00
vs 52W High—
vs 52W Low—
MA50—
MA200—
Returns
1D+0.77%
1W-2.81%
1M-1.90%
3M+32.91%
6M+84.37%
1Y+43.71%
2Y+79.67%
3Y+525.43%
5Y+1314.33%
Diwali+51.07%
Sector peers — Pharmaceuticals
CompanyCloseMkt CapTTM P/EROE
SUNPHARMA1837.30₹4.41L Cr36.4514.50%
DIVISLAB9375.00₹2.49L Cr85.0617.45%
TORNTPHARM4840.00₹1.84L Cr77.3225.70%
ZYDUSLIFE1160.00₹1.16L Cr25.8516.94%
CIPLA1394.50₹1.13L Cr33.419.75%
LAURUSLABS1954.00₹1.06L Cr96.4520.58%
AUROPHARMA1734.00₹99.77K Cr27.099.79%
DRREDDY1185.00₹98.91K Cr30.638.40%

Financial Results

Quarterly and yearly P&L · YoY % on Revenue, Total Income, Expenditure, EBITDA, EBIT, PBT, Net Profit and EPS

Standalone

16 lines · 6 periods
MetricJun-26Mar-26Dec-25Sep-25Jun-25FY25-26
Revenue641.58+119.2%776.25439.71514.27292.752,022.99
Other Income8.4912.468.051.807.8630.16
Total Income650.07+116.3%788.71447.76516.07300.612,053.15
Interest6.977.236.795.344.5823.95
Expenditure-452.53-59.8%-501.66-393.49-387.03-283.23-1,565.42
PBDT000000
EBITDA222.58+549.1%306.9176.93155.1234.29573.25
Depreciation-26.56-25.09-23.92-22.54-20.19-91.73
EBIT196.02+1290.2%281.8253.01132.5814.10481.52
PBT197.54+1036.6%287.0454.27129.0417.38487.73
Tax-50.17-74.52-13.86-32.58-3.67-124.63
Equity12.9012.9012.90012.9012.90
OPM30.3936.3912.1225.095.7823.76
Net Profit147.36+974.8%212.5240.4296.4613.71363.11
NPM22.6726.959.0318.764.5617.69
EPS114.86+975.5%165.6531.5075.1810.68283.01

Yearly results

Last 6 financial years · YoY % vs previous FY

Yearly

17 lines · 6 years
MetricFY 25-26FY 24-25FY 23-24FY 22-23FY 21-22FY 20-21
Revenue2,022.99+37.0%1,476.84-5.2%1,558.58+30.8%1,191.20+25.2%951.08+1.5%936.91
Other Income30.1620.5112.549.752.0816.10
Total Income2,053.15+37.1%1,497.35-4.7%1,571.13+30.8%1,200.95+26.0%953.15+0.0%953.01
Expenditure-1,565.42-27.4%-1,228.38-5.0%-1,170.36-18.7%-985.73-13.1%-871.41-2.8%-848.05
Interest-23.95-8.30-14-13.07-13.49-17.90
PBDT000000
EBITDA573.25+77.9%322.30-30.2%461.92+70.2%271.32+90.8%142.20-2.9%146.44
Depreciation-91.73-65.54-59.70-52.78-49.04-39.68
EBIT481.52+87.5%256.76-36.2%402.22+84.0%218.54+134.6%93.16-12.7%106.76
PBT487.73+41.2%345.37-13.8%400.77+86.2%215.21+163.3%81.74-22.1%104.96
Tax-124.63-85.95-101.17-52.09-18.21-24.67
Equity12.9012.900000
OPM (%)23.7623.0726.0018.009.0011.00
Net Profit363.11+40.0%259.43-13.4%299.60+83.7%163.12+156.8%63.53-20.9%80.30
NPM (%)17.6917.3319.0014.007.008.00
EPS (Rs)283.01+40.0%202.20-13.4%233.51+83.7%127.14+156.7%49.52-20.9%62.58
CEPS283.01202.20233.51127.1449.5262.58

Consolidated

16 lines · 6 periods
MetricJun-26Mar-26Dec-25Sep-25Jun-25FY25-26
Revenue641.58+119.2%776.25439.71514.27292.752,022.99
Other Income8.4912.468.051.807.8630.17
Total Income650.07+116.3%788.71447.76516.07300.612,053.15
Interest6.977.216.795.374.5823.95
Expenditure-452.22-59.8%-501.21-393.29-386.64-283.04-1,564.17
PBDT000000
EBITDA222.89+546.4%307.3477.13155.5434.48574.51
Depreciation-26.56-25.09-23.92-22.54-20.19-91.74
EBIT196.33+1273.9%282.2553.2113314.29482.77
PBT197.85+1026.1%287.4954.48129.4417.57488.98
Tax-50.17-74.82-13.90-32.58-3.67-124.98
Equity12.9012.900012.9012.90
OPM30.4436.4512.1725.085.8423.82
Net Profit147.67+962.4%212.6740.5796.8513.90364
NPM22.7226.969.0618.774.6217.73
EPS115.10+962.8%165.7631.6275.4910.83283.71

Yearly results

Last 6 financial years · YoY % vs previous FY

Yearly

17 lines · 6 years
MetricFY 25-26FY 24-25FY 23-24FY 22-23FY 21-22FY 20-21
Revenue2,022.99+37.0%1,476.84-5.2%1,558.58+30.8%1,191.20+25.2%951.08+1.5%936.91
Other Income30.1720.5112.549.752.0816.10
Total Income2,053.15+37.1%1,497.35-4.7%1,571.13+30.8%1,200.95+26.0%953.15+0.0%953.01
Expenditure-1,564.17-27.4%-1,227.42-4.9%-1,169.69-18.7%-985.20-13.1%-870.99-2.7%-847.68
Interest-23.95-8.30-14-13.07-13.50-17.90
PBDT000000
EBITDA574.51+77.7%323.27-30.1%462.59+70.2%271.85+90.6%142.63-2.8%146.81
Depreciation-91.74-65.55-59.70-52.78-49.04-39.68
EBIT482.77+87.3%257.72-36.0%402.89+83.9%219.07+134.1%93.59-12.6%107.13
PBT488.98+41.2%346.33-13.7%401.44+86.1%215.75+162.6%82.16-22.0%105.33
Tax-124.98-86.22-101.36-52.23-18.34-24.70
Equity12.9012.900000
OPM (%)23.8223.1325.5517.968.6211.05
Net Profit364+39.9%260.11-13.3%300.08+83.5%163.52+156.2%63.82-20.8%80.63
NPM (%)17.7317.3719.1013.626.708.46
EPS (Rs)283.71+39.9%202.74-13.3%233.89+83.5%127.45+156.2%49.74-20.9%62.85
CEPS283.71202.74233.89127.4549.7462.85

Corporate Actions

Dividends, bonus issues, and stock splits

Dividend

16
YearTypeAmountEx-Date
2026Final Dividend3424 Jul 2026
2025Final Dividend1218 Jul 2025
2024Final Dividend1412 Jul 2024
2023Final Dividend1011 Jul 2023
2022Final Dividend514 Jul 2022
2021Final Dividend329 Jun 2021
2021Interim Dividend210 Nov 2020
2020Interim Dividend218 Feb 2020
2019Final Dividend1.227 Jun 2019
2016Final Dividend204 Aug 2016
2015Final Dividend1.506 Aug 2015
2014Final Dividend1.516 Jun 2014
2014Special Dividend1.516 Jun 2014
2013Final Dividend1.224 Jul 2013
2009Final Dividend3.513 Jul 2009
2008Final Dividend2.517 Jul 2008

Bonus

0

No bonus history.

Split

0

No split history.

Loading company dashboard...
Fetching ratios, charts, and peers